*Astrazeneca Pharma India Ltd.* | *CMP* Rs. 3023 | *M Cap* Rs. 7558 Cr | *52 W H/L* 4910/2959
(Nirmal Bang Retail Research)
*Result is declining*
Revenue from Operations came at Rs. 197.7 Cr (12.7% QoQ, -5.6% YoY) vs QoQ Rs. 175.4 Cr, YoY Rs. 209.5 Cr
EBIDTA came at Rs. 17.7 Cr (13% QoQ, -50.6% YoY) vs QoQ Rs. 15.6 Cr, YoY Rs. 35.8 Cr
EBITDA Margin came at 8.9% vs QoQ 8.9%, YoY 17.1%
Adj. PAT came at Rs. 11.9 Cr vs QoQ Rs. 10.2 Cr, YoY Rs. 26.3 Cr
Quarter EPS is Rs. 4.8
Share is trading at P/E of 107.2x TTM EPS